Dataset Information


Transcription profiling of mouse prostate cancer TRAMP-C2 treated with demethylating agent 5-aza-2-deoxycytidine vs untreated to identify silenced transcripts

ABSTRACT: Gene expression profiling of TRAMP-C2, transgenic adenocarcinoma of mouse prostate, cell line was done after treating the cells with DNA demethylating agent 5-aza-2'-deoxycytidine (5azadC; Sigma-Aldrich, St. Louis, MO) and histone deacetylase inhibitor trichostatin A (TSA; Sigma-Aldrich), both separately and in combination. These treatments relieve epigenetic modifications, and thus reveal potentially epigenetically silenced genes amongst the genes with increased expression after the treatments.

ORGANISM(S): Mus musculus  

DISEASE(S): Prostate Cancer

SUBMITTER: Hanna E Rauhala   

PROVIDER: E-MEXP-1611 | ArrayExpress | 2014-05-02


altmetric image


Sorry, this publication's infomation has not been loaded in the Indexer, please go directly to PUBMED or Altmetric.

Similar Datasets

2014-05-02 | E-MEXP-2313 | ArrayExpress
2014-05-02 | E-MEXP-1610 | ArrayExpress
2014-05-02 | E-MEXP-1252 | ArrayExpress
2014-05-02 | E-MEXP-936 | ArrayExpress
2014-05-02 | E-MEXP-2029 | ArrayExpress
2014-05-02 | E-MEXP-3256 | ArrayExpress
2014-05-02 | E-MEXP-3255 | ArrayExpress
2014-05-02 | E-MEXP-3258 | ArrayExpress
2014-05-02 | E-MEXP-3257 | ArrayExpress
2014-05-02 | E-MEXP-3254 | ArrayExpress